Cargando…
Natural history and outcome in chinese patients with gastroenteropancreatic neuroendocrine tumours: - a 17-year retrospective analysis
BACKGROUND: There is rising incidence of gastroenteropancreatic neuroendocrine tumours (GEP- NETs) in many parts of the world, but epidemiological data from Asian populations is rare. METHODS: We conducted a retrospective study in a tertiary medical centre in Hong Kong, using updated diagnostic crit...
Autores principales: | Chan, Doris T., Luk, Andrea O. Y., So, W. Y., Kong, Alice P. S., Chow, Francis C. C., Ma, Ronald C. W., Lo, Anthony W. I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766724/ https://www.ncbi.nlm.nih.gov/pubmed/26911576 http://dx.doi.org/10.1186/s12902-016-0087-9 |
Ejemplares similares
-
Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours
por: Ahn, H K, et al.
Publicado: (2013) -
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
por: Ramage, John K, et al.
Publicado: (2011) -
Liver metastases in gastroenteropancreatic neuroendocrine tumours – treatment methods
por: Gut, Paweł
Publicado: (2020) -
The Multidisciplinary Team for Gastroenteropancreatic Neuroendocrine Tumours: The Radiologist’s Challenge
por: Granata, Vincenza, et al.
Publicado: (2019) -
Targeted therapy of gastroenteropancreatic neuroendocrine tumours: preclinical strategies and future targets
por: Aristizabal Prada, E T, et al.
Publicado: (2017)